Trial Information

Summary: Heartburn/GERD

Are you troubled by frequent episodes of heartburn and/or GERD related symptoms? Have you been diagnosed with GERD?

A group of medications, called proton pump inhibitors, have been shown to promote healing of erosions and thus, resolution of symptoms and improved quality of life.

This 16-week, 6-visit research study is designed to compare the effectiveness of two PPIs, Rabeprazole ER 50mg (Aciphex® extended-release) to Esomeprazole (Nexium®) 40mg for the relief of symptoms and healing.

You may qualify if you are:

  • Between the ages of 18-75
  • Experiencing frequent episodes of heartburn/GERD symptoms
  • Generally in good health
  • Willing to undergo screening procedures which may include Endoscopy

All study related physical exams, procedures and research medication will be provided at no cost. Compensation is available for time and travel.

Contact:

Recruiting Coordinator
Clinical Research Associates, Inc.
2222 State Street, Suites B & D
Nashville, TN 37203
Telephone: 615-329-2222
Email:

Profile Page: Clinical Research Associates, Inc., Nashville, TN

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:44:45 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA